Form 8-K Silo Pharma, Inc. For: Aug 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Silo Pharma acquires software assets from Parkview Consulting for stock
August 19, 2026 5:20 PM EDTSilo Pharma, Inc. (NASDAQ: SILO) entered into an asset purchase agreement with Parkview Consulting LLC on August 18, 2026, acquiring software, technology, domain names, and related intellectual property.
In exchange for the assets, Silo Pharma issued 165,000 shares of common stock, par value $0.0001 per share,... More



